213 related articles for article (PubMed ID: 32272434)
1. Characterizing false-positive fluorescence in situ hybridization results by mate-pair sequencing in a patient with chronic myeloid leukemia and progression to myeloid blast crisis.
Lopes JL; Webley M; Pitel BA; Pearce KE; Smadbeck JB; Johnson SH; Vasmatzis G; Sukov WR; Greipp PT; Hoppman NL; Ketterling RP; Baughn LB; Finn L; Peterson JF
Cancer Genet; 2020 May; 243():48-51. PubMed ID: 32272434
[TBL] [Abstract][Full Text] [Related]
2. Utilizing next-generation sequencing to characterize a case of acute myeloid leukemia with t(4;12)(q12;p13) in the absence of ETV6/CHIC2 and ETV6/PDGFRA gene fusions.
Koleilat A; McGarrah PW; Olteanu H; Van Dyke DL; Smadbeck JB; Johnson SH; Vasmatzis G; Hoppman NL; Xu X; Ketterling RP; Greipp PT; Baughn LB; Patnaik MS; Peterson JF
Cancer Genet; 2022 Jan; 260-261():1-5. PubMed ID: 34781094
[TBL] [Abstract][Full Text] [Related]
3. Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with atypical chronic myeloid leukemia.
Safley AM; Sebastian S; Collins TS; Tirado CA; Stenzel TT; Gong JZ; Goodman BK
Genes Chromosomes Cancer; 2004 May; 40(1):44-50. PubMed ID: 15034867
[TBL] [Abstract][Full Text] [Related]
4. Use of mate-pair sequencing to characterize a complex cryptic BCR/ABL1 rearrangement observed in a newly diagnosed case of chronic myeloid leukemia.
Peterson JF; Pitel BA; Smoley SA; Smadbeck JB; Johnson SH; Vasmatzis G; Kearney HM; Greipp PT; Hoppman NL; Baughn LB; Ketterling RP
Hum Pathol; 2019 Jul; 89():109-114. PubMed ID: 30267776
[TBL] [Abstract][Full Text] [Related]
5. Expression of the NUP98/HOXA9 fusion transcript in the blast crisis of Philadelphia chromosome-positive chronic myelogenous leukaemia with t(7;11)(p15;p15).
Yamamoto K; Nakamura Y; Saito K; Furusawa S
Br J Haematol; 2000 May; 109(2):423-6. PubMed ID: 10848835
[TBL] [Abstract][Full Text] [Related]
6. Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia.
Aypar U; Smoley SA; Pitel BA; Pearce KE; Zenka RM; Vasmatzis G; Johnson SH; Smadbeck JB; Peterson JF; Geiersbach KB; Van Dyke DL; Thorland EC; Jenkins RB; Ketterling RP; Greipp PT; Kearney HM; Hoppman NL; Baughn LB
Eur J Haematol; 2019 Jan; 102(1):87-96. PubMed ID: 30270457
[TBL] [Abstract][Full Text] [Related]
7. A complex three-way translocation with deletion of the TP53 gene in a blast crisis chronic myeloid leukemia patient.
Kokate P; Dalvi R; Mandava S
J Cancer Res Ther; 2015; 11(4):1037. PubMed ID: 26881646
[TBL] [Abstract][Full Text] [Related]
8. BCR-ABL1 positive AML or CML in blast crisis? A pediatric case report with inv(3) and t(9;22) in the initial clone.
Behrens YL; Schienke A; Davenport C; Lentes J; Tauscher M; Steinemann D; Rasche M; Knirsch S; Joachim S; Reinhardt D; Schlegelberger B; Göhring G
Cancer Genet; 2021 Jun; 254-255():70-74. PubMed ID: 33647814
[TBL] [Abstract][Full Text] [Related]
9. Chronic myeloid leukemia blast crisis presented with AML of t(9;22) and t(3;14) mimicking acute lymphocytic leukemia.
Liu K; Hu J; Wang X; Li L
J Clin Lab Anal; 2019 Oct; 33(8):e22961. PubMed ID: 31218758
[TBL] [Abstract][Full Text] [Related]
10. Characterization of 6q abnormalities in childhood acute myeloid leukemia and identification of a novel t(6;11)(q24.1;p15.5) resulting in a NUP98-C6orf80 fusion in a case of acute megakaryoblastic leukemia.
Tosi S; Ballabio E; Teigler-Schlegel A; Boultwood J; Bruch J; Harbott J
Genes Chromosomes Cancer; 2005 Nov; 44(3):225-32. PubMed ID: 16028218
[TBL] [Abstract][Full Text] [Related]
11. Detection of a cryptic
Peterson JF; Pitel BA; Smoley SA; Smadbeck JB; Johnson SH; Vasmatzis G; Koon SJ; Webley MR; McGrath M; Bayerl MG; Baughn LB; Rowsey RA; Ketterling RP; Greipp PT; Hoppman NL
Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30936193
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal aberrations during progression of chronic myeloid leukemia identified by cytogenetic and molecular cytogenetic tools: implication of 1q12-21.
Su XY; Wong N; Cao Q; Yu LZ; Niu C; Wickham N; Johnson PJ; Chen Z; Chen SJ
Cancer Genet Cytogenet; 1999 Jan; 108(1):6-12. PubMed ID: 9973917
[TBL] [Abstract][Full Text] [Related]
13. NUP98 is fused to topoisomerase (DNA) IIbeta 180 kDa (TOP2B) in a patient with acute myeloid leukemia with a new t(3;11)(p24;p15).
Nebral K; Schmidt HH; Haas OA; Strehl S
Clin Cancer Res; 2005 Sep; 11(18):6489-94. PubMed ID: 16166424
[TBL] [Abstract][Full Text] [Related]
14. Uncommon karyotypic abnormality, t(11;19)(q23;p13.3), in a patient with blastic phase of chronic myeloid leukemia.
Suzuki K; Sugawara T; Kowata S; Utsugizawa T; Ito S; Murai K; Ishida Y
Cancer Genet Cytogenet; 2004 Apr; 150(2):159-63. PubMed ID: 15066325
[TBL] [Abstract][Full Text] [Related]
15. A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome.
Zagaria A; Anelli L; Albano F; Storlazzi CT; Liso A; Roberti MG; Buquicchio C; Liso V; Rocchi M; Specchia G
Cancer Genet Cytogenet; 2004 Apr; 150(1):81-5. PubMed ID: 15041230
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence in situ hybridization dissection of a chronic myeloid leukemia case bearing the apparently balanced translocations (9;22)(q34;q11.2) and (11;11)(p15;q13).
Malvestiti F; Colombo D; Perego D; Rodeschini O; Finelli P; Larizza L; Giardino D
Cancer Genet Cytogenet; 2009 Jan; 188(1):42-7. PubMed ID: 19061779
[TBL] [Abstract][Full Text] [Related]
17. The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA.
Baxter EJ; Hochhaus A; Bolufer P; Reiter A; Fernandez JM; Senent L; Cervera J; Moscardo F; Sanz MA; Cross NC
Hum Mol Genet; 2002 Jun; 11(12):1391-7. PubMed ID: 12023981
[TBL] [Abstract][Full Text] [Related]
18. Constitutional chromosome rearrangements that mimic the 2017 world health organization "acute myeloid leukemia with recurrent genetic abnormalities": A study of three cases and review of the literature.
Peterson JF; Pitel BA; Smoley SA; Smadbeck JB; Johnson SH; Vasmatzis G; Pearce KE; He R; Kelemen K; Al-Mondhiry HAB; Lamparella NE; Hoppman NL; Kearney HM; Baughn LB; Ketterling RP; Greipp PT
Cancer Genet; 2019 Jan; 230():37-46. PubMed ID: 30497985
[TBL] [Abstract][Full Text] [Related]
19. Molecular cytogenetic characterization of a novel additional chromosomal aberration in blast crisis of a Ph-positive chronic myeloid leukemia.
Storlazzi CT; Anelli L; Surace C; Rocchi M; Albano F; Pastore D; Liso V; Specchia G
Cancer Genet Cytogenet; 2002 Apr; 134(2):109-13. PubMed ID: 12034521
[TBL] [Abstract][Full Text] [Related]
20. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
